Sino-American immunotherapy-focused biotech LTZ Therapeutics and UK pharma major GSK have entered into a strategic research ...
UK pharma major AstraZeneca (LSE: AZN) has gained US approval for Koselugo (selumetinib) in adults with neurofibromatosis ...
Industry analyst GlobalData has highlighted the significance of US pharma major Merck's (NYSE: MRK) plan to buy US biotech ...
Swiss pharma giant Novartis (NOVN: VX) has announced plans to expand its operations in North Carolina, USA, creating a new ...
US biotech Dewpoint Therapeutics has announced that the US Food and Drug Administration (FDA) has granted Fast Track ...
Cambridge, USA-based mRNA vaccines company Moderna today announced the expansion of its US manufacturing capabilities with ...
The US-China Economic and Security Review Commission has presented its 2025 annual report to Congress in the USA.
Merck & Co, known as MSD outside of the USA and Canada, today announced that the European Commission (EC) has approved a new ...
The landscape of phosphodiesterase 3/4 (PDE3/4) inhibitors is experiencing a significant transformation in 2025, driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback